A New Pancreatic Cancer Pill Lists at $39,800 a Month, and What Patients Actually Owe Varies Widely

Rasonque lists at about $477,600 a year. Here is what Medicare and commercially insured patients may actually pay for the new pancreatic cancer pill.

Have A Referral?